Table 1.
Pathophysiology | Associated conditions | |
---|---|---|
Immune | Autoantibody-mediated inhibition or rapid clearance |
Autoimmune disease Systemic lupus erythematosus (SLE) Rheumatoid arthritis Malignancy Solid tumours Haematologic malignancy Medications Isoniazid Monoclonal gammopathy of undetermined significance (MGUS) |
Non-immune | Hyper-consumption |
Surgery Disseminated intravascular coagulation (DIC) Inflammatory bowel disease Henoch-Schoenlein purpura (HSP) Sepsis Thrombosis Pulmonary embolism, stroke |
Hypo-synthesis |
Liver disease Leukaemia Medications Valproate Tocilizumab |